ImmVue Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$4M
- Investors
-
1
ImmVue Therapeutics General Information
Description
Developer of a small-molecule-based therapeutic platform designed to modulate cell activities through allosteric modulation. The company's platform offers allosteric agonists and inhibitors of interleukin-2-inducible T-cell kinase and Bruton's tyrosine kinase, enabling patients with enhanced immune response against treatment-resistant cancers.
Contact Information
Website
www.immvue.comCorporate Office
- 101 College Street
- Suite 200
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- 101 College Street
- Suite 200
- Toronto, Ontario M5G 1L7
- Canada
ImmVue Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 19-Mar-2025 | $4M | Completed | Startup | ||
| 1. Seed Round | 01-Aug-2021 | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ImmVue Therapeutics Patents
ImmVue Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025230982-A1 | Itk-ph domain inhibitors and their uses | Pending | 30-Apr-2024 | ||
| WO-2025230998-A1 | Tec kinase agonists and their use in enhancing lymphocyte activation | Pending | 30-Apr-2024 |
ImmVue Therapeutics Signals
ImmVue Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Novatio Ventures | Venture Capital | Minority |
ImmVue Therapeutics FAQs
-
When was ImmVue Therapeutics founded?
ImmVue Therapeutics was founded in 2017.
-
Where is ImmVue Therapeutics headquartered?
ImmVue Therapeutics is headquartered in Toronto, Canada.
-
What is the size of ImmVue Therapeutics?
ImmVue Therapeutics has 6 total employees.
-
What industry is ImmVue Therapeutics in?
ImmVue Therapeutics’s primary industry is Biotechnology.
-
Is ImmVue Therapeutics a private or public company?
ImmVue Therapeutics is a Private company.
-
What is ImmVue Therapeutics’s current revenue?
The current revenue for ImmVue Therapeutics is .
-
How much funding has ImmVue Therapeutics raised over time?
ImmVue Therapeutics has raised $5.6M.
-
Who are ImmVue Therapeutics’s investors?
Novatio Ventures has invested in ImmVue Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process